TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia
Brief Summary: This proposal aims to demonstrate the feasibility and acceptability of adapting TEAMcare for patients with schizophrenia. The aim of this innovative mental health center-based team intervention is to improve diabetes, cardiovascular and psychiatric outcomes among patients with poorly controlled type 2 diabetes. The study will be conducted in two phases over the 2-year grant period.

Phase 1. Development of the adapted TEAMcare intervention and training of team members.

Phase 2. During year 2, we will implement the intervention on the caseload of 40 outpatients at Harborview Mental Health Services with schizophrenia and poorly controlled type 2 diabetes. The intervention involves the management of subjects' diabetes, hypertension, and hyperlipidemia by a CMHC diabetes team for 6 months (advanced nurse specialist on-site at supervised in weekly meetings by a psychiatrist and a UW Diabetes Center endocrinologist).

The primary aim of this pilot research grant is to evaluate the feasibility of implementing this complex intervention, in order to guide the design of a larger scale efficacy study (R01). Both process and outcome measures will be evaluated at baseline, and at 3- and 6-month follow-up visits for the 40 subjects enrolled in this feasibility trial.


Options:
A: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Patient Peer Support and Empowerment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient Peer Support and Empowerment | Intervention Type: BEHAVIORAL; Name: Patient Peer Support and Empowerment; Assigned to Arm(s): Patient Peer Support and Empowerment | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual care
B: Arm Label: Pt. 1 Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: Pt. 1 Supportive Therapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Supportive Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Pt. 1 Behavioral Activation | Intervention Type: BEHAVIORAL; Name: Supportive Therapy; Assigned to Arm(s): Pt. 1 Supportive Therapy
C: Arm Label: TEAMcare treatment of diabetes; Type: ACTIVE_COMPARATOR; Interventions: Other: TEAMcare treatment of diabetes | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: TEAMcare treatment of diabetes; Assigned to Arm(s): TEAMcare treatment of diabetes
D: Arm Label: EBMeDS group; Type: EXPERIMENTAL; Interventions: Behavioral: The EBMeDS system, Other: Evidence Linker | Arm Label: Control group; Type: OTHER; Interventions: Other: Evidence Linker | Intervention Type: BEHAVIORAL; Name: The EBMeDS system; Assigned to Arm(s): EBMeDS group | Intervention Type: OTHER; Name: Evidence Linker; Assigned to Arm(s): Control group, EBMeDS group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest - A Randomized Trial Comparing Mild and Moderate Therapeutic Hypothermia (CAPITAL CHILL)
Brief Summary: This trial is currently a single-center, randomized, double-blind investigator initiated prospective clinical trial initiated at the University of Ottawa Heart Institute (UOHI). The plan is to expand the trial shortly as a multi-center project. The patients for this study will be recruited amongst comatose survivors of out-of-hospital cardiac arrest (OHCA). The aim of this study is to determine whether neurologic outcomes at six months are improved with moderate (31 degrees Celsius) versus mild (34 degrees Celsius) therapeutic hypothermia (TH) following return of spontaneous circulation (ROSC) in patients suffering OHCA, with ROSC defined as the resumption of sustained perfusing cardiac activity.

The primary outcome will be the proportion of patients experiencing death or a poor neurologic outcome at six months after out of hospital cardiac arrest.


Options:
A: Arm Label: control treatment; Type: NO_INTERVENTION; Interventions: Other: Rapid infusion of 2 liters of 4oC normal saline, Drug: Rapid infusion of cold normal saline | Intervention Type: OTHER; Name: Rapid infusion of 2 liters of 4oC normal saline; Assigned to Arm(s): control treatment | Intervention Type: DRUG; Name: Rapid infusion of cold normal saline; Assigned to Arm(s): control treatment
B: Arm Label: Moderate hypothermia; Type: OTHER; Interventions: Other: Therapeutic Hypothermia | Arm Label: Mild Hypothermia; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic Hypothermia | Intervention Type: OTHER; Name: Therapeutic Hypothermia; Assigned to Arm(s): Mild Hypothermia, Moderate hypothermia
C: Arm Label: Normothermia; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard care with early treatment of fever | Arm Label: Hypothermia; Type: EXPERIMENTAL; Interventions: Procedure: Targeted temperature management to 33°C | Intervention Type: PROCEDURE; Name: Targeted temperature management to 33°C; Assigned to Arm(s): Hypothermia | Intervention Type: PROCEDURE; Name: Standard care with early treatment of fever; Assigned to Arm(s): Normothermia
D: Arm Label: Targeted controlled temperature between 32.5 and 33.5°C; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Targeted controlled temperature between 32.5 and 33.5°C, Procedure: Targeted controlled temperature between 36.5 and 37.5°C | Arm Label: Targeted controlled temperature between 36.5 and 37.5°C; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Targeted controlled temperature between 36.5 and 37.5°C | Intervention Type: PROCEDURE; Name: Targeted controlled temperature between 32.5 and 33.5°C; Assigned to Arm(s): Targeted controlled temperature between 32.5 and 33.5°C | Intervention Type: PROCEDURE; Name: Targeted controlled temperature between 36.5 and 37.5°C; Assigned to Arm(s): Targeted controlled temperature between 32.5 and 33.5°C, Targeted controlled temperature between 36.5 and 37.5°C

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
Brief Summary: To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays.

* Randomized controlled arm : Placebo versus Ramosetron injection
* Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Placebo
B: Arm Label: Methylprednisolone; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone 125mg | Arm Label: placebo/sodium chloride; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 2 ml | Intervention Type: DRUG; Name: Methylprednisolone 125mg; Assigned to Arm(s): Methylprednisolone | Intervention Type: DRUG; Name: Sodium Chloride 2 ml; Assigned to Arm(s): placebo/sodium chloride
C: Arm Label: Ramosetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramosetron | Intervention Type: DRUG; Name: Ramosetron; Assigned to Arm(s): Ramosetron
D: Arm Label: Dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone, Drug: LIA Combination Mixture | Arm Label: Saline; Type: SHAM_COMPARATOR; Interventions: Other: 0.9% NaCl Placebo, Drug: LIA Combination Mixture | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: OTHER; Name: 0.9% NaCl Placebo; Assigned to Arm(s): Saline | Intervention Type: DRUG; Name: LIA Combination Mixture; Assigned to Arm(s): Dexamethasone, Saline

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors
Brief Summary: This study will assess the comparative effectiveness, cost-effectiveness and sustainability of two telemonitoring interventions in reducing blood pressure and recurrent stroke among 450 high-risk Black and Hispanic stroke patients. The primary hypothesis is that home blood pressure telemonitoring supplemented with individualized, culturally tailored telephone-based nurse case management will have greater effects on blood pressure reduction and stroke recurrence and, while it will be more costly, it will also be more cost-effective than home blood pressure telemonitoring alone. Results of this study will provide strong empirical evidence to inform clinical guidelines and practice, which may lead to reductions in stroke disparities in the United States.


Options:
A: Arm Label: internet based intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: internet based vascular risk factor intervention | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: internet based vascular risk factor intervention; Assigned to Arm(s): internet based intervention
B: Arm Label: Home BP Telemonitoring (HBPTM); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home BP Telemonitoring (HBPTM) | Arm Label: HBPTM + Nurse Case Management (NCM); Type: EXPERIMENTAL; Interventions: Behavioral: Home BP Telemonitoring (HBPTM), Behavioral: Nurse Case Management (NCM) | Intervention Type: BEHAVIORAL; Name: Home BP Telemonitoring (HBPTM); Assigned to Arm(s): HBPTM + Nurse Case Management (NCM), Home BP Telemonitoring (HBPTM) | Intervention Type: BEHAVIORAL; Name: Nurse Case Management (NCM); Assigned to Arm(s): HBPTM + Nurse Case Management (NCM)
C: Arm Label: Algorithm-based care; Type: OTHER; Interventions: Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin | Arm Label: Health-promotion; Type: OTHER; Interventions: Behavioral: Health Promotion | Intervention Type: DRUG; Name: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin; Assigned to Arm(s): Algorithm-based care | Intervention Type: BEHAVIORAL; Name: Health Promotion; Assigned to Arm(s): Health-promotion
D: Arm Label: Memory Training Program; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Healthy Lifestyle Training Program; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Lifestyle Training Program | Intervention Type: BEHAVIORAL; Name: Healthy Lifestyle Training Program; Assigned to Arm(s): Healthy Lifestyle Training Program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness of Pregnancy Failure Management Regimens
Brief Summary: The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.


Options:
A: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Manual vacuum aspiration (MVA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: surgery Manual vacuum aspiration (MVA) | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: PROCEDURE; Name: surgery Manual vacuum aspiration (MVA); Assigned to Arm(s): Manual vacuum aspiration (MVA)
B: Arm Label: hospital- based vaginal misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: vaginal misoprostol | Arm Label: extended low dose oral misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: buccal/sublingual misoprostol | Intervention Type: DRUG; Name: vaginal misoprostol; Assigned to Arm(s): hospital- based vaginal misoprostol | Intervention Type: DRUG; Name: buccal/sublingual misoprostol; Assigned to Arm(s): extended low dose oral misoprostol
C: Arm Label: misoprostol plus mifepristone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Drug: Mifepristone | Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol, misoprostol plus mifepristone | Intervention Type: DRUG; Name: Mifepristone; Assigned to Arm(s): misoprostol plus mifepristone
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Device: new crosslinked hyaluronan gel | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: new crosslinked hyaluronan gel; Assigned to Arm(s): Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness of Pregnancy Failure Management Regimens
Brief Summary: The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.


Options:
A: Arm Label: pitocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: mifepristone and oxytocin | Arm Label: misopristol; Type: ACTIVE_COMPARATOR; Interventions: Drug: mifepristone and misopristol | Intervention Type: DRUG; Name: mifepristone and misopristol; Assigned to Arm(s): misopristol | Intervention Type: DRUG; Name: mifepristone and oxytocin; Assigned to Arm(s): pitocin
B: Arm Label: misoprostol plus mifepristone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Drug: Mifepristone | Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol, misoprostol plus mifepristone | Intervention Type: DRUG; Name: Mifepristone; Assigned to Arm(s): misoprostol plus mifepristone
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: MIFEPRISTONE 200 mg and misoprostol 400 µg | Intervention Type: DRUG; Name: MIFEPRISTONE 200 mg and misoprostol 400 µg; Assigned to Arm(s): 1
D: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: 600 mcg misoprostol | Arm Label: Surgical treatment; Type: OTHER; Interventions: Procedure: Surgical treatment | Intervention Type: DRUG; Name: 600 mcg misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: PROCEDURE; Name: Surgical treatment; Assigned to Arm(s): Surgical treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness of Pregnancy Failure Management Regimens
Brief Summary: The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.


Options:
A: Arm Label: misoprostol by midwife; Type: OTHER; Interventions: Other: misoprostol by midwife | Arm Label: Misoprostol by physician; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: misoprostol by midwife; Assigned to Arm(s): misoprostol by midwife
B: Arm Label: misoprostol plus mifepristone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Drug: Mifepristone | Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol, misoprostol plus mifepristone | Intervention Type: DRUG; Name: Mifepristone; Assigned to Arm(s): misoprostol plus mifepristone
C: Arm Label: Midlevel provider; Type: OTHER; Interventions: Other: Type of provider | Arm Label: Physician arm; Type: OTHER; Interventions: Other: Type of provider | Intervention Type: OTHER; Name: Type of provider; Assigned to Arm(s): Midlevel provider, Physician arm
D: Arm Label: midwife; Type: EXPERIMENTAL; Interventions: Other: Midwife | Arm Label: Physician; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Midwife; Assigned to Arm(s): midwife

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to determine the effect of a four months school-based physical activity intervention on cognition, academic achievement, physical activity and aerobic fitness in 12-15 year old adolescents.


Options:
A: Arm Label: Physical activity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual practice | Intervention Type: BEHAVIORAL; Name: Physical activity intervention; Assigned to Arm(s): Physical activity intervention | Intervention Type: BEHAVIORAL; Name: Usual practice; Assigned to Arm(s): Control
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cycling to school; Type: EXPERIMENTAL; Interventions: Behavioral: Cycling to school | Intervention Type: BEHAVIORAL; Name: Cycling to school; Assigned to Arm(s): Cycling to school
C: Arm Label: COPE/Healthy Lifestyles TEEN Program; Type: EXPERIMENTAL; Interventions: Behavioral: COPE/Healthy Lifestyles TEEN Program. | Arm Label: Healthy Teens Attention Control Program; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Healthy Teens Attention Control Program | Intervention Type: BEHAVIORAL; Name: COPE/Healthy Lifestyles TEEN Program.; Assigned to Arm(s): COPE/Healthy Lifestyles TEEN Program | Intervention Type: BEHAVIORAL; Name: Healthy Teens Attention Control Program; Assigned to Arm(s): Healthy Teens Attention Control Program
D: Arm Label: Intervention group- Health-E-PALS; Type: EXPERIMENTAL; Interventions: Other: Health-E-PALS- | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health-E-PALS-; Assigned to Arm(s): Intervention group- Health-E-PALS

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Benefit and Tolerability of a Probiotic Product in Subjects With Increased Susceptibility to Common Cold
Brief Summary: The objective of this study is to assess the benefit and tolerability of a probiotic product in subjects with increased susceptibility to common cold.


Options:
A: Arm Label: Lactobacillus; Type: EXPERIMENTAL; Interventions: Biological: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Bifidobacterium animalis subsp. lactis; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Bifidobacterium animalis subsp. lactis | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Bifidobacterium animalis subsp. lactis; Assigned to Arm(s): Bifidobacterium animalis subsp. lactis
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: low calcium milk of 180 ml | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml + probiotics | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: regular milk of 180 ml + probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: low calcium milk of 180 ml; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml + probiotics; Assigned to Arm(s): 3 | Intervention Type: DIETARY_SUPPLEMENT; Name: regular milk of 180 ml + probiotics; Assigned to Arm(s): 4
D: Arm Label: Probiotics; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Predictive Value of AMH (AMH=Anti Müllerian Hormone ) in IVF (IVF=In Vitro Fertilization ); a Prospective Randomized Controlled Trial
Brief Summary: The primary aim of this trial is to compare two groups of women undergoing IVF (IVF=in vitro fertilisation ) treatment, to investigate if assessment of AMH (AMH=Anti-Müllerian hormone ), in addition to assessment of maternal age, AFC (AFC=antral follicle count ) and BMI (BMI=body mass index ) gives a more optimal COH (COH=controlled ovarian stimulation than does assessment of only age, AFC and BMI, measured as number of patients obtaining 5-12 oocytes during COH.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Follitropin Delta (FE 999049) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin Alfa (GONAL-F) | Intervention Type: DRUG; Name: Follitropin Delta (FE 999049); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Follitropin Alfa (GONAL-F); Assigned to Arm(s): B
B: Arm Label: Flare Up; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flare up | Arm Label: Microdose GnRh; Type: EXPERIMENTAL; Interventions: Drug: Microdose GnRh | Intervention Type: DRUG; Name: Microdose GnRh; Assigned to Arm(s): Microdose GnRh | Intervention Type: DRUG; Name: Flare up; Assigned to Arm(s): Flare Up
C: Arm Label: FE 999049 6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FE 999049 12 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: FOLLISTIM 150 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: follitropin beta | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): FE 999049 12 µg, FE 999049 6 µg, FE 999049 9 µg | Intervention Type: DRUG; Name: follitropin beta; Assigned to Arm(s): FOLLISTIM 150 IU
D: Arm Label: AMH-group; Type: EXPERIMENTAL; Interventions: Other: AMH-analysis | Arm Label: Non-AMH-group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AMH-analysis; Assigned to Arm(s): AMH-group

Answer: D